Yulisar SE - Medikaloka Hermina MD Director
| HEAL Stock | IDR 1,070 15.00 1.38% |
Insider
Yulisar SE is MD Director of Medikaloka Hermina PT
| Age | 65 |
| Phone | 62 21 857 2525 |
| Web | https://www.herminahospitals.com |
Medikaloka Hermina Management Efficiency
The company has return on total asset (ROA) of 0.0704 % which means that it generated a profit of $0.0704 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1398 %, meaning that it generated $0.1398 on every $100 dollars invested by stockholders. Medikaloka Hermina's management efficiency ratios could be used to measure how well Medikaloka Hermina manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Yoke Loh | Astra International Tbk | N/A | |
| Meliza Rusli | Astra International Tbk | 49 | |
| Ninda Djohaeri | Semen Indonesia Persero | 63 | |
| Seow Goh | Unilever Indonesia Tbk | 59 | |
| Arif Hudaya | Unilever Indonesia Tbk | 50 | |
| Stefanus Indrayana | Indofood Sukses Makmur | N/A | |
| Riska Sabrina | Unilever Indonesia Tbk | 38 | |
| David Widjaja | United Tractors Tbk | N/A | |
| Reski Damayanti | Unilever Indonesia Tbk | 43 | |
| Mark Wakeford | Indofood Sukses Makmur | 59 | |
| Supranoto Tirtodidjojo | Astra International Tbk | N/A | |
| Nataza Perdamenta | United Tractors Tbk | N/A | |
| Padwestiana Kristanti | Unilever Indonesia Tbk | N/A | |
| Endang Handajani | United Tractors Tbk | N/A | |
| Chiew Cheok | Astra International Tbk | 62 | |
| Akihiro Murakami | Astra International Tbk | 51 | |
| Arif Burhantoyib | United Tractors Tbk | N/A | |
| Endro Wahyono | Astra International Tbk | N/A | |
| Vilihati Surya | Astra International Tbk | N/A | |
| FXL Kesuma | Astra International Tbk | 57 | |
| Rahman Kurniawan | Semen Indonesia Persero | N/A | |
Management Performance
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0704 |
Medikaloka Hermina Leadership Team
Elected by the shareholders, the Medikaloka Hermina's board of directors comprises two types of representatives: Medikaloka Hermina inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medikaloka. The board's role is to monitor Medikaloka Hermina's management team and ensure that shareholders' interests are well served. Medikaloka Hermina's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medikaloka Hermina's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arie Wahyudi, Head Legal | ||
| Binsar Simorangkir, Medical and Compliance Director | ||
| Joni Agus, Head Audit | ||
| Yulisar SE, MD Director | ||
| Husen Sutakaria, Vice President Commissioner | ||
| Muyi MM, Head Marketing | ||
| Darwin Noerhadi, Commissioner | ||
| Sri MM, Head Devel | ||
| Yulisar Khiat, Operational and General Director, Corporate Secretary | ||
| Alexander Rusli, Independent Commissioner | ||
| MB BA, Commissioner | ||
| Hastiyudo MBA, B Devel | ||
| Aristo Setiawidjaja, Strategic Development and Finance Director, Independent Director | ||
| Hasmoro, President Director | ||
| MM MHA, Pres Director | ||
| Paulus Gunawan, President Commissioner | ||
| Sudarsono, Commissioner | ||
| Heridadi, Independent Commissioner |
Medikaloka Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medikaloka Hermina a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0704 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 23.44 T | |||
| Shares Outstanding | 14.48 B | |||
| Shares Owned By Insiders | 51.07 % | |||
| Shares Owned By Institutions | 7.10 % | |||
| Price To Earning | 7.42 X | |||
| Price To Book | 6.72 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Medikaloka Hermina in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Medikaloka Hermina's short interest history, or implied volatility extrapolated from Medikaloka Hermina options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Medikaloka Hermina PT. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Medikaloka Stock analysis
When running Medikaloka Hermina's price analysis, check to measure Medikaloka Hermina's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medikaloka Hermina is operating at the current time. Most of Medikaloka Hermina's value examination focuses on studying past and present price action to predict the probability of Medikaloka Hermina's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medikaloka Hermina's price. Additionally, you may evaluate how the addition of Medikaloka Hermina to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |